Subscribe

Prognostic Factors in Aggressive Diffuse Non-Hodgkin's Lymphoma Before Therapy

Specialty:

Hematology Oncology

Objective:

ICD-10:

Description:

The probable long-term survival in patients with diffuse mixed, histiocytic or undifferentiated non-Burkitt's non-Hodgkins lymphoma can be predicted from clinical factors determined prior to initiation of therapy. This can help determine how aggressive the therapeutic regimen should be.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone